NCT07167784Completed
Ecological Momentary Assessment and Physical Activity in Patients With Inflammatory Rheumatic Diseases
Ecological Momentary Assessment to Explore Fatigue, Pain, Sleep, Mood and Physical Activity Levels in Patients With Inflammatory Rheumatic Disease
Source: ClinicalTrials.gov · Last updated 22 Apr 2026
Brief summary (registry, in English)
Chronic inflammatory rheumatic diseases (IRDs), such as rheumatoid arthritis and spondyloarthritis, can cause pain, fatigue, and mobility issues, significantly impacting patients' quality of life. Physical activity is an important part of managing these conditions, as it helps reduce pain, maintain mobility, and prevent complications. However, many patients struggle to stay active due to pain and fatigue. A better understanding of these challenges could lead to improved support and interventions. This study explores a new way to monitor the daily experiences of patients with IRDs using Ecological Momentary Assessment (EMA), a method that collects real-time data through a mobile app. The study will also use actimeters-wearable devices that track physical activity. Over 14 days, participants will answer short surveys on their phones and wear an actimeter to provide insights into how fatigue, pain, mood, and physical activity levels change throughout the day. Before this approach is implemented in a larger study, its practicality and acceptability for patients must be evaluated. This pilot study will assess whether participants find the mobile app and actimeter easy to use, how often surveys are completed, and whether frequent reminders affect participants' willingness to continue. The study will also examine the immediate and delayed effects of different symptoms on physical activity and explore factors that influence participant engagement with the protocol. By identifying potential barriers and solutions, this research will help refine future studies and improve methods for monitoring and supporting individuals with IRDs in staying active while managing symptoms.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 50 (actual)
- First submitted
- 3 Sept 2025
- Start date
- 24 Nov 2025
- Primary completion date
- 3 Apr 2026
- Lead sponsor
- University Hospital, Grenoble
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT07167784
What you commit to
- Study type: Observational
- Participants enrolled: 50
- From 24 Nov 2025 to the primary completion date, 3 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Adults (≥18 years) with a confirmed diagnosis of CIRDs, including RA or SpA, established by a rheumatologist, are eligible for inclusion.
- Adults able to understand and consent to the study protocol,
- Adults affiliated with a social security system
- Adults that have access to a digital device with internet access (e.g., smartphone or tablet).
- Non-inclusion Criteria:
- Insufficient proficiency in the French language
- Legal incapacity or deprivation of liberty
- Major cognitive impairment incompatible with repeated questionnaire completion (e.g., Alzheimer's disease)
- Pregnant or breastfeeding women
- Individuals with a history of alcohol or substance abuse, or severe psychiatric disorders that could affect adherence to the protocol or the reliability of collected data, are also excluded.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Grenoble Alpes Coordinator of this site? Confirm its status | Grenoble | France | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.